High prevalence of overweight and obesity in adults with Crohn's disease: Associations with disease and lifestyle factors

Journal of Crohn's and Colitis

Volumn 7, Issue 7, 2013, Pages

  Nic Suibhne, Treasa ^a   Raftery, Tara C ^a   McMahon, Orla ^a   Walsh, Cathal ^b   O'Morain, Colm ^a   O'Sullivan, Maria ^a  

^a ADELAIDE AND MEATH HOSPITAL   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Body Mass Index; Crohn's disease; Inflammatory bowel disease; Nutrition; Obesity; Overweight

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BODY MASS; CASE CONTROL STUDY; CONTROLLED STUDY; CROHN DISEASE; CROHN DISEASE ACTIVITY INDEX; DISEASE ASSOCIATION; FEMALE; HUMAN; LEUKOCYTE COUNT; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; OBESITY; PHYSICAL ACTIVITY; POPULATION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SOCIAL STATUS;

ADULT; ANALYSIS OF VARIANCE; BODY MASS INDEX; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CROHN DISEASE; FEMALE; HUMANS; IRELAND; LINEAR MODELS; MALE; OBESITY; OVERWEIGHT; PREVALENCE; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC;

EID: 84878652261     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2012.09.009     Document Type: Article

References (36)

1. Ogden C.L., Carroll M.D., Curtin L.R., McDowell M.A., Tabak C.J., Flegal K.M. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006, 295:1549-1555.
2. Muller-Riemenschneider F., Reinhold T., Berghofer A., Willich S.N. Health-economic burden of obesity in Europe. Eur J Epidemiol 2008, 23:499-509.
3. Nguyen G.C., Munsell M., Harris M.L. Nationwide prevalence and prognostic significance of clinically diagnosable protein-calorie malnutrition in hospitalized inflammatory bowel disease patients. Inflamm Bowel Dis 2008, 14:1105-1111.
4. Pirlich M., Schutz T., Kemps M., Luhman N., Burmester G.R., Baumann G., et al. Prevalence of malnutrition in hospitalized medical patients: impact of underlying disease. Dig Dis 2003, 21:245-251.
5. O'Sullivan M. Symposium on 'The challenge of translating nutrition research into public health nutrition'. Session 3: Joint Nutrition Society and Irish Nutrition and Dietetic Institute Symposium on 'Nutrition and autoimmune disease'. Nutrition in Crohn's disease. Proc Nutr Soc 2009, 68:127-134.
6. Sousa Guerreiro C., Cravo M., Costa A.R., Miranda A., Tavares L., Moura-Santos P., et al. A comprehensive approach to evaluate nutritional status in Crohn's patients in the era of biologic therapy: a case-control study. Am J Gastroenterol 2007, 102:2551-2556.
7. Kugathasan S., Nebel J., Skelton J.A., Markowitz J., Keljo D., Rosh J., et al. Body mass index in children with newly diagnosed inflammatory bowel disease: observations from two multicenter North American inception cohorts. J Pediatr 2007, 151:523-527.
8. Steed H., Walsh S., Reynolds N. A brief report of the epidemiology of obesity in the inflammatory bowel disease population of Tayside, Scotland. Obes Facts 2009, 2:370-372.
9. Long M.D., Crandall W.V., Leibowitz I.H., Duffy L., del Rosario F., Kim S.C., et al. Prevalence and epidemiology of overweight and obesity in children with inflammatory bowel disease. Inflamm Bowel Dis 2010, 17:2162-2168.
10. Blain A., Cattan S., Beaugerie L., Carbonnel F., Gendre J.P., Cosnes J. Crohn's disease clinical course and severity in obese patients. Clin Nutr 2002, 21:51-57.
11. Hass D.J., Brensinger C.M., Lewis J.D., Lichtenstein G.R. The impact of increased body mass index on the clinical course of Crohn's disease. Clin Gastroenterol Hepatol 2006, 4:482-488.
12. Canedo J.A., Pinto R.A., McLemore E.C., Rosen L., Wexner S.D. Restorative proctectomy with ileal pouch-anal anastomosis in obese patients. Dis Colon Rectum 2010, 53:1030-1034.
13. Crohn B.B., Ginzburg L., Oppenheimer G.D. Regional ileitis, a pathologic and clinical entity. JAMA 1932, 99:1323-1329.
14. Peyrin-Biroulet L., Chamaillard M., Gonzalez F., Beclin E., Decourcelle C., Antunes L., et al. Mesenteric fat in Crohn's disease: a pathogenetic hallmark or an innocent bystander?. Gut 2007, 56:577-583.
15. Tilg H., Moschen A.R. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006, 6:772-783.
16. Schaffler A., Scholmerich J., Buchler C. Mechanisms of disease: adipocytokines and visceral adipose tissue-emerging role in intestinal and mesenteric diseases. Nat Clin Pract Gastroenterol Hepatol 2005, 2:103-111.
17. Parmentier-Decrucq E., Duhamel A., Ernst O., Fermont C., Louvet A., Vernier-Massouille G., et al. Effects of infliximab therapy on abdominal fat and metabolic profile in patients with Crohn's disease. Inflamm Bowel Dis 2009, 15:1476-1484.
18. Gentile M., Panico S., Rubba F., Mattiello A., Chiodini P., Jossa F., et al. Obesity, overweight, and weight gain over adult life are main determinants of elevated hs-CRP in a cohort of Mediterranean women. Eur J Clin Nutr 2010, 64:873-878.
19. Pitsavos C., Panagiotakos D.B., Tzima N., Lentzas Y., Chrysohoou C., Das U.N., et al. Diet, exercise, and C-reactive protein levels in people with abdominal obesity: the ATTICA epidemiological study. Angiology 2007, 58:225-233.
20. Oliveira A., Lopes C., Severo M., Rodriguez-Artalejo F., Barros H. Body fat distribution and C-reactive protein-a principal component analysis. Nutr Metab Cardiovasc Dis 2011, 21:347-354.
21. Gil A., Maria Aguilera C., Gil-Campos M., Canete R. Altered signalling and gene expression associated with the immune system and the inflammatory response in obesity. Br J Nutr 2007, 98(Suppl. 1):S121-S126.
22. Wozniak S.E., Gee L.L., Wachtel M.S., Frezza E.E. Adipose tissue: the new endocrine organ? A review article. Dig Dis Sci 2009, 54:1847-1856.
23. Yarur A.J., Deshpande A.R., Pechman D.M., Tamariz L., Abreu M.T., Sussman D.A. Inflammatory bowel disease is associated with an increased incidence of cardiovascular events. Am J Gastroenterol 2011, 106:741-747.
24. Haapamaki J., Roine R.P., Turunen U., Farkkila M.A., Arkkila P.E. Increased risk for coronary heart disease, asthma, and connective tissue diseases in inflammatory bowel disease. J Crohns Colitis 2011, 5:41-47.
25. Lennard-Jones J.E. Classification of inflammatory bowel disease. Scand J Gastroenterol 1989, 170:2-6.
26. Central-Statistics-Office Government of Ireland CSO census - principal socio-economic results 2003.
27. Wareham N.J., Jakes R.W., Rennie K.L., Mitchell J., Hennings S., Day N.E. Validity and repeatability of the EPIC-Norfolk Physical Activity Questionnaire. Int J Epidemiol 2002, 31:168-174.
28. McCarthy S.N., Gibney M.J., Flynn A., Livingstone M.B.E. Overweight, obesity and physical activity levels in Irish adults: evidence from the North/South Ireland Food Consumption Survey. Proc Nutr Soc 2002, 6:3-7.
29. WHO Obesity: preventing and managing the global epidemic. World Health Organ Tech Rep Ser 2000, 1-253.
30. Bishop C.W., Bowen P.E., Ritchey S.J. Norms for nutritional assessment of American adults by upper arm anthropometry. Am J Clin Nutr 1981, 34:2530-2539.
31. Frisancho A.R. New norms of upper limb fat and muscle areas for assessment of nutritional status. Am J Clin Nutr 1981, 34:2540-2545.
32. Best W.R., Becktel J.M., Singleton J.W., Kern F. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976, 70:439-444.
33. Mendall M.A., Gunasekera A.V., John B.J., Kumar D. Is obesity a risk factor for Crohn's disease?. Dig Dis Sci 2011, 56:837-844.
34. Peyrin-Biroulet L., Gonzalez F., Dubuquoy L., Rousseaux C., Dubuquoy C., Decourcelle C., et al. Mesenteric fat as a source of C reactive protein and as a target for bacterial translocation in Crohn's disease. Gut 2011, 61:78-85.
35. Raftery T., O'Sullivan M. Risk factors for cardiovascular events in inflammatory bowel disease. Am J Gastroenterol 2011, 106:2042.
36. Silverberg M.S., Satsangi J., Ahmad T., Arnott I.D., Bernstein C.N., Brant S.R., et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005, 19:A5-A36. (Suppl.).